Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Judge Rejects J&J’s Third Bankruptcy Filing, Killing $9B Talcum Powder Settlement Federal bankruptcy court will not allow Johnson & Johnson to force the settlement of talcum powder lawsuits through a bankruptcy filing, sending lawsuits back to the U.S. civil court system. April 1, 2025 Irvin Jackson Add Your Comments A federal judge has rejected Johnson & Johnson’s latest attempt to use bankruptcy to settle tens of thousands of lawsuits over its talcum powder products, marking the third time the company’s controversial strategy has failed in court. The lawsuits involve more than 90,000 Baby Powder lawsuits and Shower-to-Shower lawsuits filed by women nationwide, who claim to have developed ovarian cancer and other malignancies targeting their reproductive systems. The lawsuits came after years of Johnson & Johnson promoting the products for genital use. In recent years, Johnson & Johnson has tried multiple times to limit its legal exposure by using a bankruptcy maneuver known as the “Texas Two-Step.” The strategy involves creating a new subsidiary, transferring all talc-related legal liabilities to that company, and then having the new entity file for Chapter 11 bankruptcy. If approved, it would allow J&J to settle claims for far less than what plaintiffs might receive through individual lawsuits. The company’s first two bankruptcy filings were rejected by judges who ruled that J&J wasn’t in financial distress and was acting in bad faith. In 2023, a federal appeals court dismissed a similar bankruptcy filing effort involving a J&J subsidiary called LTL Management. In 2024, J&J made a third attempt, this time filing in Texas with a new subsidiary named Red River Talc, and proposing an $8.9 billion settlement fund. The company claimed the offer had support from over 75% of plaintiffs, but critics, including the U.S. government, argued that most individual victims never got to vote on the plan. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Many plaintiffs and federal agencies have strongly opposed Johnson & Johnson’s third bankruptcy proposal. Specifically, the U.S. Department of Health and Human Services and the Department of Veterans Affairs warned that approving the deal would prevent the government from being reimbursed for medical expenses covered through Medicare, Medicaid and other public health programs for those injured by talcum powder. Furthermore, plaintiffs’ lawyers urged the court to reject the plan, arguing that it would unfairly block individuals from pursuing their lawsuits separately in civil court. Judge Rejects Third Talcum Powder Bankruptcy Attempt On March 31, Judge Lopez issued a Memorandum Decision and Order (PDF) rejecting the proposal, finding that the plan failed to meet the legal requirements of a bankruptcy settlement. Although Johnson & Johnson claimed that more than 75% of plaintiffs supported the deal, the court found this figure misleading. Judge Lopez pointed out that many actual claimants were never given the chance to vote on the proposal. Instead, some law firms had agreed to the terms on behalf of their clients without directly informing them or getting their input. “Votes are a quintessential part of plan confirmation. Votes are voices,” Judge Lopez wrote. “But the Court did not get to hear from tens of thousands of them.” He also indicated that the plan included “impermissible nonconsensual third-party releases,” noting that plaintiffs were not allowed to opt out or opt in to these releases, even if they voted against participating in the bankruptcy settlement. Judge Lopez determined that the plan would have funneled potential liability to hundreds of retailers and a now-unaffiliated spin-off company named Kenvue. “Red River’s expert witness and its Chief Legal Officer also confirmed that the plan is not feasible without including retailers in the channeling injunction,” Judge Lopez noted. “The plan was heavily negotiated, achieves potential finality, and enjoys significant support. But it cannot be confirmed.” Ultimately, Judge Lopez said there was no way to confirm that the majority of plaintiffs approve of the plan, and that it is impossible to certify their votes. He also determined that the only way the settlement plan would have worked was to suddenly include hundreds of retailers who had not been involved in the litigation previously. On the same day, Johnson & Johnson issued a press release denouncing the decision and indicating that it plans to return to the courts in an attempt to have tens of thousands of claims thrown out, despite numerous failures in the past to do so, essentially claiming that it has been targeted by a conspiracy theory involving law firms and the Courts. Judge Lopez estimated that about 10 talcum powder cancer lawsuit trials would be held per year, indicating it would take 9,000 years for the court system to address them all. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Talcum Powder Image Credit: Shutterstock: CCPang More Talcum Powder Stories Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal February 21, 2025 3,500 New Talcum Powder Cancer Lawsuits Set To Be Filed in UK February 6, 2025 Judge Urged To Reject J&J’s 3rd Talcum Powder Lawsuit Bankruptcy Deal January 30, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal February 21, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)